Tag: Glenmark

Dr Sharvil Patel, Managing Director, Zydus Lifesciences appointed as President, IPA. Glenn Saldanha, Chairman and Managing Director, Glenmark, appointed as Vice President, IPA

India and North America drive revenue growth as EBITDA and PAT margins reflect strong operational efficiency; company confident of double-digit growth ahead

IGI’s lead investigational asset, ISB 2001, has been developed using IGI’s proprietary BEAT® protein platform, for oncology and autoimmune diseases

Its focus is to reduce the number of malnourished children aged 0-5 years and to support nutritionally-at-risk pregnant and lactating women

Organized by Glenmark Foundation in partnership with IDOBRO, UN Global Compact Network India, and Impact4Nutrition

The Cover Story tracks the strides made by the Indian biotech industry towards sustainability goals. Special interview of Shivaji Dashrath Jadhav, Vice President & Head - EHS & Sustainability, Aragen Life Sciences. Expert Insights by Vikrant Agrawal, Co-founder, Care.fi and Rajeev Taneeja, Founder and CEO, Global Care. Special stories on bio-manufacturing, healthcare innovation and agri-foodtech.

Company's first presentation of data from Phase 1 study of the Trispecific ISB 2001 showed an overall response rate (ORR) of 75% in Relapsed/Refractory Multiple Myeloma

Under this strategic collaboration, Glenmark will be responsible for locally required development, registration and distribution providing access to BeiGene's innovative oncology medicines for cancer patients across India

Lirafit™ will sharply lower the daily cost of therapy by around 70% to around Rs 100; making the drug more accessible to a larger number of patients with type 2 diabetes mellitus in the country

The company partnered with more than 8000 doctors and 10,000 healthcare professionals from 42 cities across the country; with the target of reaching out to more than 10 crore Indians